FANJ
OCUL icon

Financial Architects (New Jersey)’s Ocular Therapeutix OCUL Stock Holding History

Financial Architects (New Jersey)’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-400
Closed -$2K – 1123
2019
Q2 		$2K Buy
+400
New +$1.48K ﹤0.01% 1095

Other funds holding OCUL

SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Architects (New Jersey)'s OCUL Position: Q3 2019 in Review

Financial Architects (New Jersey) sold out of Ocular Therapeutix (OCUL) in Q3 2019, closing a stake of 400 shares — an estimated $2K sold.

Financial Architects (New Jersey) first reported a position in OCUL in Q2 2019 and held it in 1 quarter. The position peaked at $2K in Q2 2019. 75 funds tracked by Wall St. Rank hold OCUL as of Q3 2019.

  • Financial Architects (New Jersey) reported no remaining Ocular Therapeutix position as of Q3 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 400 Ocular Therapeutix shares in Q3 2019, an estimated $2K.
  • Financial Architects (New Jersey) first reported a position in Ocular Therapeutix in Q2 2019 and held it in 1 quarter.
  • Financial Architects (New Jersey)'s Ocular Therapeutix position peaked at $2K in Q2 2019.
  • 75 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2019, filed 6 Nov 2019.